Acrivon Therapeutics (ACRV) Stock Chart & Stock Price History $1.30 +0.02 (+1.56%) Closing price 04:00 PM EasternExtended Trading$1.30 0.00 (0.00%) As of 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acrivon Therapeutics Stock Price Performance The Acrivon Therapeutics (ACRV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 83.63%, with a year-to-date return of -78.41%. In the past month, the stock has increased 6.56%, reflecting recent market activity. As of the latest close, Acrivon Therapeutics traded at $1.28 with a market cap of $40.13 million and volume of 454,498 shares. Receive ACRV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.52%1 Month Performance+6.56%3 Month Performance-29.73%Year-To-Date Performance-78.41%1 Year Performance-83.63% ACRV Stock Chart for Wednesday, July, 16, 2025 ACRV Chart by TradingView Acrivon Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$1.33$1.28-3.76%$1.33$1.23454,498 shs$40.13 million07/14/2025$1.32$1.33+0.76%$1.36$1.31191,015 shs$41.70 million07/11/2025$1.35$1.32-2.22%$1.35$1.31110,427 shs$41.39 million07/10/2025$1.34$1.35+0.75%$1.37$1.32205,394 shs$42.32 million07/09/2025$1.31$1.34+2.29%$1.38$1.31370,202 shs$42.01 million07/08/2025$1.25$1.31+4.80%$1.33$1.25258,953 shs$41.08 million07/07/2025$1.30$1.25-3.47%$1.31$1.25148,591 shs$39.19 million07/04/2025$1.30$1.30$1.33$1.26125,785 shs$40.61 million07/03/2025$1.29$1.30+0.39%$1.33$1.26125,785 shs$40.60 million07/02/2025$1.23$1.29+4.88%$1.39$1.23542,194 shs$40.44 million Get the Latest News and Ratings for ACRV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$1.19$1.23+3.36%$1.27$1.15396,134 shs$38.56 million06/30/2025$1.20$1.19-0.83%$1.24$1.18305,292 shs$37.31 million06/27/2025$1.31$1.20-8.40%$1.34$1.201.82 million shs$37.62 million06/26/2025$1.33$1.31-1.50%$1.33$1.25438,549 shs$41.07 million06/25/2025$1.24$1.33+7.26%$1.33$1.20733,676 shs$41.70 million06/24/2025$1.18$1.24+5.08%$1.26$1.18285,760 shs$38.87 million06/23/2025$1.18$1.18$1.22$1.15174,222 shs$36.99 million06/20/2025$1.24$1.18-4.84%$1.26$1.18251,221 shs$37.00 million06/19/2025$1.24$1.24$1.30$1.22283,795 shs$38.87 million06/18/2025$1.21$1.24+2.48%$1.30$1.22283,795 shs$38.87 million06/17/2025$1.22$1.21-0.82%$1.24$1.18239,908 shs$37.94 million06/16/2025$1.20$1.22+1.67%$1.26$1.16277,622 shs$38.25 million Related Companies DiaMedica Therapeutics Stock Chart Nuvectis Pharma Stock Chart Compugen Stock Chart Aclaris Therapeutics Stock Chart BioAge Labs Stock Chart Molecular Partners Stock Chart Alector Stock Chart Ventyx Biosciences Stock Chart Lexeo Therapeutics Stock Chart Theratechnologies Stock Chart Receive ACRV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRV) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acrivon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACRV Stock Alerts